Title: ProQR Therapeutics’ (PRQR) “Buy” Rating Reiterated at Chardan Capital
Author: MarketBeat News
Source: newsapi
Published: 2024-12-15T07:40:50Z
URL: https://www.etfdailynews.com/2024/12/15/proqr-therapeutics-prqr-buy-rating-reiterated-at-chardan-capital/
----------------------------------------
Chardan Capital restated their buy rating on shares of ProQR Therapeutics (NASDAQ:PRQR – Free Report) in a research note published on Thursday morning,Benzinga reports. Chardan Capital currently has … [+3126 chars]